A Comparative Study Between Copy Number Alterations and PRAME Immunohistochemical Pilot Study in Challenging Melanocytic Lesions
- PMID: 40227827
- PMCID: PMC11988168
- DOI: 10.3390/cancers17071218
A Comparative Study Between Copy Number Alterations and PRAME Immunohistochemical Pilot Study in Challenging Melanocytic Lesions
Abstract
Introduction: Diagnostic uncertainty for ambiguous lesions that fall on the spectrum between nevi and melanoma remains a significant challenge and can have consequences for patient management.
Methods: This study aimed to compare the diagnostic utility of preferentially expressed antigen in melanoma (PRAME) immunohistochemistry to molecular testing (FISH and SNP array) in 34 diagnostically challenging melanocytic lesions and 9 non-diagnostically challenging melanomas.
Results: We conclude that while PRAME immunohistochemistry demonstrates high specificity (96.2%) in diagnostically challenging melanocytic lesions, its low sensitivity (12.5%) suggests that it should not replace histopathological evaluation in rendering the final diagnosis.
Conclusions: These findings suggest that PRAME may serve as a useful adjunct in the diagnostic workup, particularly due to its high negative predictive value, but should be used in conjunction with other established diagnostic modalities.
Keywords: PRAME; copy number alteration; diagnostically challenging; melanoma; nevus.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- American Cancer Society Melanoma Skin Cancer Statistics. [(accessed on 12 January 2023)]. Available online: https://www.cancer.org/cancer/types/melanoma-skin-cancer/about/key-stati....
-
- American Cancer Society Risk Factors for Melanoma Skin Cancer American Cancer Society. 2000. [(accessed on 12 January 2023)]. Available online: https://www.cancer.org/cancer/melanoma-skin-cancer/causes-risks-preventi....
-
- Bataille V. Early detection of melanoma improves survival. Practitioner. 2009;253:29–32. - PubMed
-
- Elmore J.G., Barnhill R.L., Elder D.E., Longton G.M., Pepe M.S., Reisch L.M., Carney P.A., Titus L.J., Nelson H.D., Onega T., et al. Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations: Observer accuracy and reproducibility study. BMJ. 2017;357:j2813. doi: 10.1136/bmj.j2813. - DOI - PMC - PubMed
-
- Auer B., Oris B. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: Comparative genomic hybridization as a research and diagnostic tool. Dermatol. Ther. 2006;19:40–49. - PubMed
LinkOut - more resources
Full Text Sources
